Skip to main content

Table 3 Therapy and outcome

From: Prognosis of pathogen-proven acute respiratory distress syndrome diagnosed from a protocol that includes bronchoalveolar lavage: a retrospective observational study

  All patients (N = 70) Pathogen-proven ARDS group (N = 50) Pathogen-unproven ARDS group (N = 20) p
Therapy
 Neuromuscular blocking agents 12 (17) 8 (16) 4 (20) 0.732
 Corticosteroid therapy 29 (41) 20 (40) 9 (45) 0.791
 Prone position 5 (7) 3 (6) 2 (10) 0.619
 Hemodialysis 21 (30) 15 (30) 6 (30) 1.000
 VA ECMO 5 (7) 4 (8) 1 (5) 1.000
 VV ECMO 12 (17) 11 (22) 1 (5) 0.158
 Tracheostomy 28 (40) 20 (40) 8 (40) 1.000
 Appropriate antibiotic therapy for causative pathogens within day 3 48 (96)
Outcome
 Ventilator-free days of 28 days 16 (0–20) 18 (7–20) 4 (0–22) 0.112
 ICU-free days of 28 days 13 (0–16) 13 (5–16) 1 (0–15) 0.034
 ICU mortality 15 (21) 5 (10) 10 (50) 0.0006
 Hospital-free days of 28 days 0 (0–6) 0 (0–6) 0 (0–7) 0.613
 Hospital mortality 20 (29) 9 (18) 11 (55) 0.0038
  1. Values are given as the median (interquartile range) or number (%). p values were calculated using Fisher’s exact test or the Mann-Whitney U test
  2. ARDS acute respiratory distress syndrome, VA ECMO veno-arterial extracorporeal membrane oxygenation, VV veno-venous, ICU intensive care unit